Ireland

Andrew Gallagher is the co-founder and CSO of Filter, a manufacturer of innovative medical devices for patients with respiratory diseases. Filter's first product is a digital therapy for helping patients reduce the psychological symptoms of COPD. It is currently in pilot studies with clinics in the UK. Andrew wants to use the YTILI program to grow his international network and learn and share with other digital health leaders to drive health forward.